General Information
Drug ID
DR00482
Drug Name
Irbesartan
Synonyms
2-Butyl-3-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-1,3-diazaspiro(4.4)non-1-en-4-one; 2-Butyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]1,3-diaza-spiro[4.4]non-1-en-4-one; 2-butyl-3-[ p-(o-1 H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4,4]non-1-en-4-one; 2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one; 2-butyl-3-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one; 2-butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one; 2-n-butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one; 8-butyl-7-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-7,9-diazaspiro[4.4]non-8-en-6-one; Aprovel; Aprovel (TN); Avalide (TN); Avapro; Avapro (TN); BMS 186295; BMS Brand of Irbesartan; BMS-186295; BMS-186295, SR-47436,Aprovel, Karvea, Irbesartan; Bristol Myers Brand of Irbesartan; Irbesarran; Irbesartan (JAN/USAN/INN); Irbesartan [USAN:INN]; Irbetan; Karvea; Karvea (TN); Lrbesartan; SR 47436; SR-47436; SanofiWinthrop Brand of Irbesartan
Drug Type
Small molecular drug
Indication High blood pressure [ICD11: BA00] Approved [1]
Therapeutic Class
Antihypertensive Agents
Structure
3D MOL 2D MOL
Formula
C25H28N6O
Canonical SMILES
CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
InChI
InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)
InChIKey
YOSHYTLCDANDAN-UHFFFAOYSA-N
CAS Number
CAS 138402-11-6
Pharmaceutical Properties Molecular Weight 428.5 Topological Polar Surface Area 87.1
Heavy Atom Count 32 Rotatable Bond Count 7
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 5
XLogP
4.1
PubChem CID
3749
PubChem SID
11364645 , 11367207 , 11369769 , 11372006 , 11374741 , 11377931 , 11485625 , 11489491 , 11490809 , 11492936 , 11495565 , 11528645 , 12014641 , 14758693 , 14905264 , 26612692 , 26680708 , 26719813 , 26748950 , 26748951 , 29222869 , 46386566 , 46506575 , 46530573 , 47365300 , 48035232 , 48416128 , 49681744 , 49830881 , 50107493 , 5243560 , 53787775 , 56312044 , 56313979 , 57321974 , 77118987 , 7847589 , 81092816 , 8152372 , 85174437 , 85209120 , 85789259 , 91011661 , 92124749 , 92307926 , 92308458 , 92713301 , 93166505 , 93621098 , 9672
ChEBI ID
ChEBI:5959
TTD Drug ID
D00JAU
DT(s) Transporting This Drug PEPT1 Transporter Info Peptide transporter 1 Substrate [2]
References
1 Irbesartan was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 High-affinity interaction of sartans with H+/peptide transporters. Drug Metab Dispos. 2009 Jan;37(1):143-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.